
BB Biotech Investor Relations Material
Latest events

Q2 2025
25 Jul, 2025

Q1 2025
25 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BB Biotech AG
Access all reports
BB Biotech AG is an investment company specializing in biotechnology. The company focuses on building a diversified portfolio of publicly listed biotech companies, primarily in the fields of drug development and medical research. BB Biotech's investments target companies involved in innovative treatments for diseases across therapeutic areas such as oncology, rare diseases, and infectious diseases. The company is headquartered in Schaffhausen, Switzerland, and its shares are listed on the SIX.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BION
Country
🇨🇭 Switzerland